FR2073293B1 - - Google Patents

Info

Publication number
FR2073293B1
FR2073293B1 FR6945776A FR6945776A FR2073293B1 FR 2073293 B1 FR2073293 B1 FR 2073293B1 FR 6945776 A FR6945776 A FR 6945776A FR 6945776 A FR6945776 A FR 6945776A FR 2073293 B1 FR2073293 B1 FR 2073293B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR6945776A
Other languages
French (fr)
Other versions
FR2073293A1 (ja
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut Pasteur de Lille
Original Assignee
Institut Pasteur de Lille
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut Pasteur de Lille filed Critical Institut Pasteur de Lille
Priority to FR6945776A priority Critical patent/FR2073293B1/fr
Priority to CA101,323A priority patent/CA956573A/en
Priority to CH1913270A priority patent/CH533988A/fr
Priority to BE760727A priority patent/BE760727A/xx
Priority to GB6124070A priority patent/GB1326928A/en
Priority to LU62332D priority patent/LU62332A1/xx
Priority to AT1170570A priority patent/AT301749B/de
Priority to DE19702064296 priority patent/DE2064296C2/de
Priority to JP45125049A priority patent/JPS4940922B1/ja
Priority to NL7019097A priority patent/NL7019097A/xx
Priority to DK271A priority patent/DK128054B/da
Publication of FR2073293A1 publication Critical patent/FR2073293A1/fr
Application granted granted Critical
Publication of FR2073293B1 publication Critical patent/FR2073293B1/fr
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/21—Retroviridae, e.g. equine infectious anemia virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/13—Tumour cells, irrespective of tissue of origin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/26—Lymph; Lymph nodes; Thymus; Spleen; Splenocytes; Thymocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/205—Rhabdoviridae, e.g. rabies virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/13011—Gammaretrovirus, e.g. murine leukeamia virus
    • C12N2740/13034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/20011—Rhabdoviridae
    • C12N2760/20211—Vesiculovirus, e.g. vesicular stomatitis Indiana virus
    • C12N2760/20234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biomedical Technology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Hematology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR6945776A 1969-12-31 1969-12-31 Expired FR2073293B1 (ja)

Priority Applications (11)

Application Number Priority Date Filing Date Title
FR6945776A FR2073293B1 (ja) 1969-12-31 1969-12-31
CA101,323A CA956573A (en) 1969-12-31 1970-12-22 Preparation of a pathological process inhibitor and applications
CH1913270A CH533988A (fr) 1969-12-31 1970-12-23 Préparation d'un inhibiteur de processus pathologiques
BE760727A BE760727A (fr) 1969-12-31 1970-12-23 Preparation d'un inhibiteur de processus pathologiques et applications
GB6124070A GB1326928A (en) 1969-12-31 1970-12-23 Therapeutic material
LU62332D LU62332A1 (ja) 1969-12-31 1970-12-28
AT1170570A AT301749B (de) 1969-12-31 1970-12-29 Verfahren zur Herstellung eines Inhibitors pathologischer Prozesse, insbesondere Leukämie und Sarcome
DE19702064296 DE2064296C2 (de) 1969-12-31 1970-12-29 Verfahren zur Herstellung eines injizierbaren Mittels gegen Viren der Mäuseleukämien
JP45125049A JPS4940922B1 (ja) 1969-12-31 1970-12-30
NL7019097A NL7019097A (ja) 1969-12-31 1970-12-31
DK271A DK128054B (da) 1969-12-31 1971-01-04 Fremgangsmåde til fremstilling af en indibitor for patologiske processer.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR6945776A FR2073293B1 (ja) 1969-12-31 1969-12-31

Publications (2)

Publication Number Publication Date
FR2073293A1 FR2073293A1 (ja) 1971-10-01
FR2073293B1 true FR2073293B1 (ja) 1973-01-12

Family

ID=9045518

Family Applications (1)

Application Number Title Priority Date Filing Date
FR6945776A Expired FR2073293B1 (ja) 1969-12-31 1969-12-31

Country Status (11)

Country Link
JP (1) JPS4940922B1 (ja)
AT (1) AT301749B (ja)
BE (1) BE760727A (ja)
CA (1) CA956573A (ja)
CH (1) CH533988A (ja)
DE (1) DE2064296C2 (ja)
DK (1) DK128054B (ja)
FR (1) FR2073293B1 (ja)
GB (1) GB1326928A (ja)
LU (1) LU62332A1 (ja)
NL (1) NL7019097A (ja)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5330639U (ja) * 1976-08-20 1978-03-16
CH664494A5 (it) * 1979-10-11 1988-03-15 Liborio Dott Bonifacio Procedimento per preparare antidoti per la prevenzione e la cura dei tumori, dagli escrementi delle capre.
JPS5925332A (ja) * 1982-08-04 1984-02-09 Mochida Pharmaceut Co Ltd 抗腫瘍性糖蛋白質の製法
FR2568125B1 (fr) * 1984-07-25 1988-04-15 Kogo Michiko Agent anti-tumeur contenant la proteine du sucre
GB8614733D0 (en) * 1986-06-17 1986-07-23 Lefesvre A Aids treatment

Also Published As

Publication number Publication date
LU62332A1 (ja) 1971-05-27
GB1326928A (en) 1973-08-15
NL7019097A (ja) 1971-07-02
DK128054B (da) 1974-02-25
JPS4940922B1 (ja) 1974-11-06
BE760727A (fr) 1971-05-27
DE2064296A1 (de) 1971-07-15
CH533988A (fr) 1973-02-28
CA956573A (en) 1974-10-22
AT301749B (de) 1972-09-11
DE2064296C2 (de) 1984-10-25
FR2073293A1 (ja) 1971-10-01

Similar Documents

Publication Publication Date Title
AU2270770A (ja)
AU465413B2 (ja)
AU429630B2 (ja)
AU450150B2 (ja)
FR2073293B1 (ja)
AU2355770A (ja)
AU442375B2 (ja)
AU470301B1 (ja)
AU427401B2 (ja)
AU442380B2 (ja)
AU410358B2 (ja)
AU428131B2 (ja)
AU428074B2 (ja)
AU428129B2 (ja)
AU438128B2 (ja)
AU470661B1 (ja)
AU442285B2 (ja)
AU442322B2 (ja)
AU442357B2 (ja)
AU425297B2 (ja)
AU414607B2 (ja)
AU442463B2 (ja)
AU442535B2 (ja)
AU442538B2 (ja)
AU442554B2 (ja)

Legal Events

Date Code Title Description
ST Notification of lapse